Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial

scientific article published in January 2009

Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3816/CGC.2009.N.008
P698PubMed publication ID19213668

P50authorDavid I QuinnQ38327794
C P ReynoldsQ67015887
David R GandaraQ73567194
P2093author name stringDenice D Tsao-Wei
Susan Groshen
Primo N Lara
Jacek Pinski
Eric Cheung
Przemyslaw Twardowski
Barry J Maurer
Tanya Dorff
Gurkamal Chatta
Mark McNamara
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectCaliforniaQ99
phase II clinical trialQ42824440
P1104number of pages8
P304page(s)43-50
P577publication date2009-01-01
P1433published inClinical Genitourinary CancerQ332266
P1476titleOral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial
P478volume7